Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2522 Target Snapshot

Beta-galactosidase · SINGLE PROTEIN · Homo sapiens

198Compounds
124Assays
1Approved Drugs
83.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P16278. Use UniProt P16278 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P16278 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Beta-galactosidase as ChEMBL target CHEMBL2522, mapped to UniProt P16278. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Beta-galactosidase
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL2522
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P16278
Beta-galactosidase
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Beta-galactosidase is the right protein anchor across sources, using UniProt P16278 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelBeta-galactosidase
UniProt AccessionP16278
Component TypeProtein
Sequence Length677 aa

Beta-galactosidase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Beta-galactosidase, mapped to UniProt P16278. Sequence length is 677 aa.

Mapped IDP16278
Review nameBeta-galactosidase
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Approved
Assay Mix

Activity Type Distribution

IC5064.0
KI19.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4288931 9.4 IC50 0.4 Preclinical
CHEMBL4085739 8.1 IC50 8.0 Preclinical
CHEMBL4284436 8.0 IC50 10.0 Preclinical
CHEMBL1922581 6.9 IC50 125.0 Preclinical
CHEMBL3771185 6.68 IC50 210.0 Preclinical
CHEMBL1818433 6.62 IC50 240.0 Preclinical
CHEMBL4281031 6.6 IC50 250.0 Preclinical
CHEMBL4069909 6.54 Ki 290.0 Preclinical
CHEMBL1922581 6.52 Ki 300.0 Preclinical
CHEMBL205982 6.52 Ki 300.0 Preclinical
Distribution

pChEMBL Value Distribution

6
5.0
3
5.5
4
6.0
8
6.5
0
7.0
0
7.5
3
8.0
0
8.5
1
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

124
Total Assays
55
Tested Compounds
2
Assay Types
Binding — 123 assays, 55 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 86 37 5.4
assay format 35 18 5.5
tissue-based format 2 0
ADME — 1 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine